ZXDA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.612100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.429800E-01
Normal-vs-Stage2
8.037900E-02
Normal-vs-Stage3
9.168300E-02
Normal-vs-Stage4
9.580400E-01
Stage1-vs-Stage2
1.487790E-01
Stage1-vs-Stage3
4.422100E-02
Stage1-vs-Stage4
6.802800E-01
Stage2-vs-Stage3
1.305030E-01
Stage2-vs-Stage4
6.224100E-02
Stage3-vs-Stage4
9.299800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.668100E-02
Normal-vs-AfricanAmerican
3.486400E-01
Normal-vs-Asian
1.443970E-01
Caucasian-vs-AfricanAmerican
6.586600E-01
Caucasian-vs-Asian
6.699800E-01
AfricanAmerican-vs-Asian
5.202800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.862000E-02
Normal-vs-Female
1.513640E-01
Male-vs-Female
3.315200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.132200E-01
Normal-vs-Age(41-60Yrs)
2.039800E-01
Normal-vs-Age(61-80Yrs)
7.737800E-02
Normal-vs-Age(81-100Yrs)
6.193700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.631600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.513200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.448350E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.460400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.792000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.675200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.456300E-02
Normal-vs-Daily Drinker
7.852200E-02
Normal-vs-Weekly Drinker
1.869050E-01
Normal-vs-Occasional Drinker
1.032180E-01
Normal-vs-Social Drinker
4.505200E-01
Non Drinker-vs-Daily Drinker
4.350600E-01
Non Drinker-vs-Weekly Drinker
7.477200E-01
Non Drinker-vs-Occasional Drinker
6.864800E-01
Non Drinker-vs-Social Drinker
1.917780E-01
Daily Drinker-vs-Weekly Drinker
4.229000E-01
Daily Drinker-vs-Occasional Drinker
3.365600E-01
Daily Drinker-vs-Social Drinker
8.732500E-02
Weekly Drinker-vs-Occasional Drinker
9.883000E-01
Weekly Drinker-vs-Social Drinker
3.829200E-01
Occasional Drinker-vs-Social Drinker
3.063600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.372300E-02
Normal-vs-Grade 2
2.130300E-02
Normal-vs-Grade 3
4.231500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.810200E-01
Grade 1-vs-Grade 3
7.520600E-01
Grade 1-vs-Grade 4
9.372300E-02
Grade 2-vs-Grade 3
6.064600E-01
Grade 2-vs-Grade 4
2.130300E-02
Grade 3-vs-Grade 4
4.231500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.175900E-02
Normal-vs-NonDiabetic
5.621800E-02
Diabetic-vs-NonDiabetic
7.692200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.188300E-02
Normal-vs-NoPancreatitis
7.133900E-02
Pancreatitis-vs-NoPancreatitis
5.205600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.776050E-01
Normal-vs-N1
8.350500E-02
N0-vs-N1
7.509800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.617190E-01
Normal-vs-TP53-NonMutant
3.979400E-01
TP53-Mutant-vs-TP53-NonMutant
1.394570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
